SCHEMBL508211

SCHEMBL508211

CC(O)n1cccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11493460 0.81 NOS1 (0.34)
SCHEMBL17801172 0.81 NOS1 (0.34)
SCHEMBL5713342 0.79 NOS1 (0.34)
SCHEMBL174399 0.79
SCHEMBL6022879 0.77
Bromide SCHEMBL27878723 0.77
SCHEMBL29962089 0.76 NOS1 (0.39)
SCHEMBL23666770 0.75
SCHEMBL16295346 0.75
SCHEMBL11152177 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101367764-A Novel synthesis process for 5-amino-1-hydroxyethyl pyrazole or the like UNIV CHANGSHA SCIENCE (CN) 2009-02-18 CN claimed
EP-1309561-B1 1H-PYRAZOL DERIVATIVES, METHOD FOR PRODUCING THEM AND THEIR USE AS NITRIFICATION INHIBITORS PIESTERITZ STICKSTOFF (DE) 2006-10-11 EP claimed
WO-2026090348-A1 THE USE OF SON OF SEVENLESS (SOS) INHIBITOR COMPOUNDS SUCH AS 7-SUBSTITUTED BENZOFURANS TO TREAT CANCER Mirati Therapeutics, Inc. (US) 2026-04-30 WO disclosed
EP-4598916-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF Amgen Inc. (US) 2025-08-13 EP disclosed
EP-4430047-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2024-09-18 EP disclosed
EP-4352060-A1 TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS Incyte Corporation (US) 2024-04-17 EP disclosed
WO-2024076672-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-04-11 WO disclosed
CN-113278022-B Pyrazolopyrimidine compound, pharmaceutical composition and application thereof 南京纳丁菲医药科技有限公司 2023-12-12 CN disclosed
CN-115572299-B Lung cancer c-Met targeted small molecule PET imaging agent and application thereof 哈尔滨医科大学 2023-10-31 CN disclosed
EP-4229060-A1 COMPOSITIONS AND METHODS FOR TREATING KIT-AND PDGFRA-MEDIATED DISEASES Blueprint Medicines Corporation (US) 2023-08-23 EP disclosed
US-11691963-B2 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors AJAX THERAPEUTICS, INC. (US) 2023-07-04 US disclosed
EP-0073880-A2 Substituted phenoxyphenoxyalkanecarbonacid-azolyl-alkyl esters, process for their preparation and their use as herbicides and plant growth regulators BAYER AG (DE) 1983-03-16 EP disclosed
EP-0070990-A2 Substituted phenoxybenzoic acid-azolylalkyl esters, process for their preparation and their herbicidal application BAYER AG (DE) 1983-02-09 EP disclosed
US-4369056-A Substituted pyrazolylmethyl-haloacetanilide compounds and herbicidal compositions BAYER AKTIENGESELLSCHAFT (DE) 1983-01-18 US disclosed
EP-0008057-B1 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED ALPHA-HALOACETANILIDES BAYER AG (DE) 1982-05-12 EP disclosed
EP-0008056-B1 N-SUBSTITUTED PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND N-HYDROXYALKYLPYRAZOLES OBTAINED IN THE COURSE OF THIS PROCESS BAYER AG (DE) 1981-09-16 EP disclosed
EP-0008091-B1 SUBSTITUTED N-PYRAZOLYLMETHYL-HALOACETANILIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES BAYER AG (DE) 1981-08-12 EP disclosed
EP-0008056-A1 N-substituted pyrazole derivatives, process for their preparation and N-hydroxyalkylpyrazoles obtained in the course of this process BAYER AG (DE) 1980-02-20 EP disclosed
EP-0008091-A1 Substituted N-pyrazolylmethyl-haloacetanilides, process for their preparation and their use as herbicides BAYER AG (DE) 1980-02-20 EP disclosed
EP-0008057-A1 Process for the preparation of N-substituted alpha-haloacetanilides BAYER AG (DE) 1980-02-20 EP disclosed